Page last updated: 2024-09-04

ym 09151-2 and cycloserine

ym 09151-2 has been researched along with cycloserine in 1 studies

Compound Research Comparison

Studies
(ym 09151-2)
Trials
(ym 09151-2)
Recent Studies (post-2010)
(ym 09151-2)
Studies
(cycloserine)
Trials
(cycloserine)
Recent Studies (post-2010) (cycloserine)
2496132,583192482

Protein Interaction Comparison

ProteinTaxonomyym 09151-2 (IC50)cycloserine (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)4.835
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)2.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dall'Olio, R; Gandolfi, O1

Other Studies

1 other study(ies) available for ym 09151-2 and cycloserine

ArticleYear
The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.
    Psychopharmacology, 1993, Volume: 110, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzazepines; Cycloserine; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Stereotyped Behavior

1993